G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
54.00
-0.20 (-0.37%)
Jun 12, 2025, 1:30 PM CST
Market Cap 3.20B
Revenue (ttm) 273.77M
Net Income (ttm) 118.95M
Shares Out 59.00M
EPS (ttm) 2.02
PE Ratio 26.88
Forward PE n/a
Dividend 0.76 (1.40%)
Ex-Dividend Date n/a
Volume 22,970
Average Volume 13,471
Open 54.40
Previous Close 54.20
Day's Range 53.50 - 54.50
52-Week Range 45.00 - 61.70
Beta -0.90
RSI 48.70
Earnings Date Aug 7, 2025

About G&E Herbal Biotechnology

G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products. It offers Hepanamin capsules; botoniocal healthcare products; botanical anti-aging cosmetics, which includes facial cleansing essence, botonic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; and adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 39
Stock Exchange Taipei Exchange
Ticker Symbol 4911
Full Company Profile

Financial Performance

In 2024, G&E Herbal Biotechnology's revenue was 249.03 million, an increase of 37.25% compared to the previous year's 181.44 million. Earnings were 102.06 million, an increase of 40.97%.

Financial Statements

News

There is no news available yet.